FDA approves OraQuick for use in saliva. On March 25, the FDA approved the first rapid test for HIV in oral fluids.
Branson
Bernard M
BM
Laboratory Determinants & Diagnostics Section, Division of HIV/AIDS Prevention, CDC, USA.
D015492:AIDS Serodiagnosis / Q000379:methods*; D006678:HIV / Q000276:immunology / Q000302:isolation & purification; D015483:HIV Antibodies / Q000032:analysis*; D015658:HIV Infections / Q000175:diagnosis*; D006801:Humans; D012463:Saliva / Q000821:virology*; D012680:Sensitivity and Specificity; D014481:United States; D014486:United States Food and Drug Administration
D015483:HIV Antibodies